FDA approves Gadopiclenol injection for the U.S. market Bracco Announces FDA Approval of Gadopiclenol Injection, a New Macrocyclic High-Relaxivity Gadolinium-Based Contrast Agent which will be commercialized as VUEWAY™ (gadopiclenol) injection and VUEWAY™ (gadopiclenol) Pharmacy Bulk Package by Bracco.

Iomeron 400 Iomeron® is a tri-iodinated non-ionic monomeric contrast medium for radiology.

CT Exprès CT Exprès™ Contrast Media Delivery System.

Empower CTA+ Efficiency and Control at your fingertips.

Contrast Induced Nephropathy Contrast Induced Nephropathy

Data protection Data Protection

Cookie Policy Cookie Policy

Search Search

Pharmacovigilance Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse events or any other drug-related problem, with the aim to improve the care and safety of patients and to contribute to the protection of public health.

HSE Policy The Health, Safety, and Environment (HSE) Policy conveys the principles of the Bracco Group on health, safety, and environmental matters.